baber/WOPTO huggingface dataset:
Patent JP-3144640-B2 (JP)
IPC: H02P29/00
Filed: 1990-10-31
Granted: 2001-03-12
Abstract: Procedure and apparatus for the control of a hoisting motor, in which procedure an a.c. motor (3) used as a hoisting motor is fed via a frequency converter (2) connected to the supply mains (L1-L3). The frequency converter is controlled by a control unit (9,10). The voltage of the supply mains is determined using a voltage measuring unit (11). When an undervoltage condition prevails in the supply mains, the rotational speed and/or acceleration of the hoisting motor are/is reduced.
Patent JP-H043868-B2 (JP)
IPC: G03G/
Filed: 1983-11-04
Abstract: An electrographic, two-component dry developer composition comprising charged toner particles and oppositely charged, magnetic carrier particles, which (a) comprise a magnetic material exhibiting "hard" magnetic properties, as characterized by a coercivity of at least 300 gauss and (b) an induced magnetic moment of at least 20 EMU/gm when in an applied field of 1000 gauss. The developer is employed in combination with a magnetic applicator comprising a rotatable magnetic core and an outer, nonmagnetizable shell to develop electrostatic images.
Patent JP-3542804-B2 (JP)
IPC: C12P21/08
Filed: 1994-06-20
Granted: 2004-07-14
Abstract: Nucleotide sequence (I) encoding a polypeptide (II) with SCCE (Stratum corneum chymotryptic enzyme) activity is new. Also new are (1) expression systems contg. (I); (2) non-human organisms contg. such systems; (3) (recombinant) polypeptide (IIa) also its fragments and homologues, having a 253 amino acid sequence reproduced in the specification.
Patent JP-2559438-B2 (JP)
Inventor: ANDERSON PORTER W
IPC: A61K39/385
Filed: 1987-05-01
Granted: 1996-12-04
Abstract: An immunogenic conjugate which is the reductive amination product of an immunogenic capsular polymer fragment having at least one reducing group and derived from a bacterial capsular polymer of a bacterial pathogen, and a bacterial toxin or toxoid. The invention also relates to methods for the preparation of the conjugates, a vaccine containing the conjugates which elicits effective levels of anti-capsular polymer antibodies in humans. Also disclosed are methods for inducing active immunization against systemic infection in young mammals caused by bacterial pathogens comprising the administration of an immunogenic amount of the abovedescribed conjugate. In a preferred embodiment, the capsular polymer fragment prior to conjugation has at least one aldehyde group at each end of the fragment. The final conjugate made with such capsular polymers has a lattice or network structure, and provides extremely high levels of anti-capsular polymer antibodies in infants.
Patent JP-3954101-B2 (JP)
IPC: A61K39/155
Filed: 1996-06-19
Granted: 2007-08-08
Abstract: Vaccine comprising a virus having the designation ATCC VR2509 is claimed. Also claimed are: (1) an isolated and purified North American porcine reproductive and respiratory syndrome (PRRS) virus (PRRSV) strain where the strain has the designation ATCC VR2509, and (2) an isolated and purified PRRSV strain, wherein the strain gives plaques having an average dia. of  2 mm when the plaques are obtd. by a method comprising: (a) inoculating an aliquot of cells with the strain, where the cells have the designation ATCC VR2509, where the aliquot is obtd. from a confluent monolayer of the cells maintained in Eagle's min. essential medium (MEM) supplemented with 3% fetal calf serum and 0.15% sodium carbonate, where the aliquot includes 1-2\*105 cells/ml of MEM, (b) incubating the aliquot at 37  deg C for 60 mins, (c) removing the inoculum from the aliquot, (d) washing the aliquot with MEM, (e) resuspending the aliquot in 5 ml of 2X MEM and 1.6% boiled Noble agar supplemented with 250 ~mg of diethylaminoethyl (DEAE)- dextran, (f) plating the aliquot and (g) further incubating the aliquot at 37  deg C for 5 days in CO2 incubator to give the plaques.
Patent JP-3925873-B2 (JP)
IPC: B65D85/50
Filed: 1998-06-12
Granted: 2007-06-06
Abstract: A case-ready package and method of reducing discoloration in meat or poultry products enclosed within such packages when the packages are disposed in a stack of two or more packages. A non-textured and substantially smooth gas-permeable substrate is attached to the lower surface of the packages to allow air to flow into an underlying package in a stack of packages, thereby preventing or minimizing premature discoloration of packaged fresh meat or poultry product due to insufficient oxygen flow into such packages when disposed in a stack. In addition, the substrate may contain printed product indicia either directly or in the form of a label attached thereto.
Patent JP-2562194-B2 (JP)
IPC: G01N33/74
Filed: 1988-08-05
Granted: 1996-12-11
Abstract: Determn. of two or more analytes in a liq. sample is effected by: (a) loading ligands specific for each analyte onto a support in discrete locations such that each location has not more than 0.1 V/K moles of ligand, where V (litres) is the vol. of the sample and K (l/mole) is the equilibrium constant of the ligand for the analyte; (b) contacting the support with the sample; and (c) measuring the amts. of bound analytes by a competitive or non-competitive assay method using a labelled reagent for each ligand, the reagent being capable of recognising the filled or unfilled binding sites on the ligand.
Patent JP-3596892-B2 (JP)
IPC: A61L27/22
Filed: 1994-09-07
Granted: 2004-12-02
Abstract: Injectable implant compositions for soft tissue augmentation comprise elastin and collagen and a biocompatible carrier. An injectable implant composition for soft tissue augmentation is derived from the ligamentum nuchae which has been treated to remove non-collagenous and non-elastinous proteins. Methods of making an injectable implant composition for soft tissue augmentation from the ligamentum nuchae are described.
Patent JP-3802558-B2 (JP)
IPC: A01N33/18
Filed: 1994-09-15
Granted: 2006-07-26
Abstract: PCT No. PCT/GB94/02014 Sec. 371 Date Apr. 8, 1996 Sec. 102(e) Date Apr. 8, 1996 PCT Filed Sep. 15, 1994 PCT Pub. No. WO95/07613 PCT Pub. Date Mar. 23, 1995An oil in water emulsion comprises a continuous aqueous phase and a discontinuous oil phase which is either a hydrophobic liquid which is immiscible with the aqueous phase or is a solid phase obtained by providing an emulsion in the aqueous phase of a solution of potentially solid material in the hydrophobic liquid and converting this solution to a solid phase, and the emulsion is stabilized by the inclusion of water-soluble stabilizing polymer in the aqueous phase and oil solubilizing stabilizing material, generally polymer, in the oil phase. The or each polymer is preferably a copolymer of hydrophilic and hydrophobic groups, preferably being formed by copolymerization of water-soluble monomer and oil-soluble monomer that provide the desired groups in the polymer without further reaction. Partially hydrolyzed polyvinyl alcohol can be used as the water-soluble polymer.
Patent JP-4057049-B2 (JP)
IPC: A61K38/42
Filed: 1994-09-20
Granted: 2008-03-05
Abstract: The invention relates to the chromatographic purification of hemoglobin. The method for purifying hemoglobin from the raw solution containing the admixture of proteinaceous origin provides for the use of ion-exchange chromatography. The raw solution containing 0.1-20% hemoglobin. At the first stage, anion-exchanging column is used when the admixtures are more acidic than hemoglobin, or cation-exchanging column is used when the admixtures are more alkaline than hemoglobin. The continuous flow of the solution results first in the complete saturation of the column with hemoglobin and the admixtures with high affinity to the column, then the column is overloaded following the substitution of hemoglobin. At the second stage, the ion-exchanger alternative to that used at the first stage is employed. Again, upon the complete saturation and overloading of the column, hemoglobin is substituted.
Patent JP-3187836-B2 (JP)
IPC: A63B49/08
Filed: 1993-01-21
Granted: 2001-07-16
Abstract: A sheet material which includes an apertured top layer formed of a non-absorbant, thermally non-conductive thermoplastic material, a non-woven layer having a first portion formed of a mixture of moisture-wicking and moisture-absorbent fibers affixed to the top layer, and, optionally, a second portion including fibers which are non-adsorbent and non-absorbent, and, in various embodiments, a barrier layer and/or cushioning layer forming a laminate in which the nonwoven layer is sandwiched between the top layer and such other layers. The chemical formulation of the top layer of thermoplastic material can be varied to alter its coefficient of friction or degree of slip resistance depending upon the requirements of a particular application.
Patent JP-4222451-B2 (JP)
IPC: C01B7/19
Filed: 1996-09-24
Granted: 2009-02-12
Abstract: A process for separating and recovering hydrogen fluoride from a mixture with an organic compound especially a fluorine-containing compound by extraction with a solution of an alkali metal fluoride in hydrogen fluoride, phase separation and recovery. A process for producing a fluorine-containing organic compound by fluorinating a starting material with hydrogen fluoride and similarly recovering hydrogen fluoride from the product stream. The solution may be anhydrous or aqueous.
Patent JP-3940961-B2 (JP)
IPC: G01T3/06
Filed: 1997-10-07
Granted: 2007-07-04
Abstract: The present invention concerns a monitor for measuring both the gamma spectrum and neutrons emitted by a spent nuclear fuel pin or pin assembly. According to the invention, it comprises a lead block (1) presenting a front face (8) intended to be brought close to said pin (7) or assembly to be measured and incorporating   - a gamma detector (2) for gamma spectroscopy located close to a rear face of said block and associated with a collimator (4) extending from said front face to said gamma detector, - two neutron detectors (3) which extend parallelly to each other and to said front face and are disposed symmetrically on either side of the axis of said collimator (4) close to said front face (8).   <IMAGE>
Patent JP-3734831-B2 (JP)
IPC: C12N15/00
Filed: 1994-12-28
Granted: 2006-01-11
Abstract: Homologous recombination is employed to inactivate genes, particularly genes associated with MHC antigens. Particularly, each of the  beta 2- microglobulin gene and the IFN- gamma R gene is inactivated for reducing or eliminating the expression of functional MHC antigens. The resulting cells may be used as universal donor cells. In addition, embryonic stem cells may be modified by homologous recombination for use in producing chimeric or transgenic mammalian hosts, which may be used as source of universal donor organs, or as models for drug and transplantation therapies. Methods for homologous recombination in non-transformed mammalian somatic cells are also described.
Patent JP-3928000-B2 (JP)
IPC: G06F17/50
Filed: 1996-11-13
Granted: 2007-06-13
Abstract: A method for selecting lead-candidate compounds capable of binding to a receptor biopolymer from a database containing information about atomic types and mode of covalent bonds of compounds by using a computer, comprising a step of selecting candidate compounds from compounds stored in the database based on quantitative, two-dimensional and/or three-dimensional information of one or more query molecules capable of binding to the biopolymer. The query molecules can be obtained by an automatic structure construction method, for example. The lead-candidate compounds capable of binding to the biopolymer can be retrieved rapidly by using an ordinary personal computer or workstation without requiring huge calculation.
Patent JP-3844357-B2 (JP)
IPC: B05C5/02
Filed: 1995-01-05
Granted: 2006-11-08
Abstract: The present invention relates to a process and a device for the production of a flat administration form comprising a preparation that contains pharmaceutical active substances. The flowable preparation is conveyed to an applicator unit (12) by means of a metering pump, and flows through a distribution chamber (2) having a distribution plate (3) provided with passages (4). This application device (12) transfers the preparation onto a layer of the flat administration form (6,11) which is therefor contacted with the distribution plate (3) for a short time.
Patent JP-2922649-B2 (JP)
IPC: G09F3/02
Filed: 1995-01-11
Granted: 1999-07-26
Abstract: A composite stamp has two parts that are used in combination to provide the finished stamp on a piece of mail. One part bears a decorative design, and the second part bears the normal identifying postage-related information including country, denomination, etc. and also has an area on which the first part is to be adhered. Both parts have adhesive backs and may, for example, be provided in dry-peelable form on a suitable carrier substrate.
Patent JP-4014645-B2 (JP)
IPC: C12M3/02
Filed: 1997-11-18
Granted: 2007-11-28
Abstract: Mammalian cells capable of producing cartilage are cultured under a shear flow stress of about 1 to about 100 dynes/cm2 to produce artificial cartilage for surgical transplantation to replace damaged or missing cartilage. Shear flow stressed cells display enhanced maintenance of chondrocyte phenotype and produce an extracellular matrix containing an enhanced ratio of type II collagen to type I collagen. The cells may be chondrocytes, chondrocyte stem cells or cells such as myoblasts or fibroblasts that transdifferentiate into chondrocytes. A bioreactor is used containing a growth chamber having a substrate on which the cells capable of producing cartilage are attached, and means for applying relative movement between a liquid culture medium and the substrate to provide the shear flow stress. The substrate may be a scaffold, or a nonporous surface such as the surface of a rotatable drum or disc, or the surface of a static plate that supports cell growth in a monolayer. Cartilage is produced by covering the substrate with a liquid growth medium, inoculating into the medium cells capable of producing cartilage, allowing the cells to attach to the substrate, applying and maintaining relative movement between the growth medium and the cells to provide the shear flow stress to produce shear flow stressed cells, and culturing the shear flow stressed cells to produce cartilage.
Patent JP-3941880-B2 (JP)
IPC: C08F220/04
Filed: 1996-07-19
Granted: 2007-07-04
Abstract: PCT No. PCT/EP96/03203 Sec. 371 Date Apr. 23, 1998 Sec. 102(e) Date Apr. 23, 1998 PCT Filed Jul. 19, 1996 PCT Pub. No. WO97/06190 PCT Pub. Date Feb. 20, 1997The present invention relates to a powdery, cross-linked polymer absorbing water and aqueous liquids formed of polymerized, unsaturated, acid groups-containing monomers that are present as salts neutralized to the extent of at least 50 mol-% and which optionally comprise further monomers which are copolymerizable with the acid groups-containing monomers as well as water-soluble polymers, the polymer being formed of acidic, polymerized monomers partially neutralized to the extent of 5-30 mol-%, relative to the acid groups-containing monomer portion. The polymer has a high retention, high liquid absorption under pressure, high swelling pressure, and a low content of soluble components. The present invention further relates to a process for the production of said polymer and to its use as a component in sanitary articles which absorb body fluids and in wound dressings, in current-conducting and light-transmitting cables, as soil conditioners, as a component in packaging materials and in depot materials for the controlled release of active substances.
Patent JP-3262339-B2 (JP)
IPC: C11D1/29
Filed: 1998-12-17
Granted: 2002-03-04
Abstract: A clear liquid detergent containing, in water, an alkylbenzenesulfonic anion surfactant, liquid sodium silicate, a polyoxyethylene alkyl or aryl ether nonionic surfactant and an alkylethersulfate salt anionic surfactant.
Patent JP-3851355-B2 (JP)
IPC: F24F13/08
Filed: 1998-02-27
Granted: 2006-11-29
Abstract: PCT No. PCT/FR98/00388 Sec. 371 Date Oct. 19, 1999 Sec. 102(e) Date Oct. 19, 1999 PCT Filed Feb. 27, 1998 PCT Pub. No. WO98/39604 PCT Pub. Date Sep. 11, 1998The invention concerns a device for separating (100) a first (10) from a second zone (20) in which prevails different kinds of environment. The invention is characterised in that it comprises: a buffer zone (110) extending along a longitudinal axis X between the first and second zones, and communicating via an inlet (111) with the first zone (10), and via an outlet (112) with the second zone (20); means for injecting air (120, 120a) opening at the inlet of the buffer zone, for injecting on either side of said longitudinal axis X, towards the outlet of said buffer zone, two clean air jets (121, 122) at high speed, extending along oblique directions (Y1, Y2) relative to the axis X, which cross each other in a region between the inlet and the central region (113) of said buffer zone, so as to form an impassable barrier which separates the first from the second zone.
Patent JP-3229335-B2 (JP)
IPC: H04B3/23
Filed: 1998-03-05
Granted: 2001-11-19
Abstract: A speech processing apparatus which, in the process of performing echo canceling by using a pseudo acoustic echo signal, continuously uses an impulse response used for the previous frame as an impulse response to generate the pseudo acoustic echo signal when a voice is contained in the microphone input signal, and which uses a newly updated impulse response when a voice is not contained in the microphone input signal. <IMAGE>
Patent JP-3950485-B2 (JP)
IPC: A41G5/00
Filed: 1998-09-29
Granted: 2007-08-01
Abstract: A wig fitting implement which performs the fitting of a wig to the head surely and stably, can be put on and off easily, has no bad influence like eczema and a rash to the head skin and has an excellent workability and a method of the use thereof are provided; said wig fitting implement 1 comprises a net-like base 2 divided into four regions of the surface, the back, the left and the right (A side, B side, C side and D side), and double-sided tapes 3 (A1, B1, C1 and D1) and protective tapes 4 (A2, B2, C2 and D2) are stuck to each region. B1 of the B side is stuck to the surrounding rim part 13 of the flexible planar component 9 of the wig 7, and the natural hair 12 of the head skin 10 passes through the penetration holes 6 and is held between C1 and B1 to fix. The fitting of the natural hair 12 is performed surely by inserting the natural hair 12 up to the root thereof through the penetration holes 6 of the wig fitting implement 1. <IMAGE>
Patent PL-161513-B2 (PL)
IPC: F16B9/00
Filed: 1990-12-27
Abstract: Składana przegroda, znamienna tym,
że stanowią ją przynajmniej dwa walce (1)
zaopatrzone w podłużne kształtowe wycięcia
(2) oraz przynajmniej jedna płyta (4) posiadająca
podłużne kształtowe wypusty (3), które
wprowadzane są w podłużne kształtowe
wycięcia (2) walców (1) przy czym każdy z
walców (1) zaopatrzony jest w gniazdo (5),
w którym osadzony jest łącznik (7) posiadający
przynajmniej jeden występ (6) oraz jedno
gniazdo (8).
Patent ES-2264845-B2 (ES)
Title: Sistema de analisis y gestion de imagenes quirurgicas.
Inventor: GOMEZ GONZALEZ EMILIO
IPC: G06T1/00
Filed: 2004-04-14
Granted: 2007-07-01
Abstract: Sistema de análisis y gestión de imágenes quirúrgicas (sagiq). La presente invención tiene por objeto un sistema de análisis y gestión de imágenes quirúrgicas que consiste en una unidad portátil que consta de dos módulos a la que se conectan los diversos dispositivos generadores de imagen y señales, incluyendo señales ópticas, señales de dispositivos de diagnóstico e imágenes radiológicas permitiendo su integración y combinación para facilitar su visualización por el usuario. El sistema propuesto tiene aplicación clínica y docente y permite su uso en quirófanos y unidades de cuidados intensivos.
Patent ES-2659092-B2 (ES)
Title: Composición farmaceútica que comprende inhibidores selectivos de la recaptación de la serotonina y galanina (1-15)
Inventor: FLORES BURGESS ANTONIO
IPC: A61P25/24
Filed: 2017-02-20
Granted: 2018-06-29
Abstract: Composición farmacéutica que comprende inhibidores selectivos de la recaptación de la serotonina y galanina (1-15). La presente invención se refiere al uso de galanina (1-15) o una de sus sales farmacéuticamente aceptables para ser utilizado en combinación con un inhibidor de la recaptación de serotonina o cualquier otro compuesto que provoque un aumento significativo de la síntesis de receptores 5HT1A postsinápticos en áreas terminales. En particular, la presente invención se refiere al uso de GAL(1-15) o una sal farmacéuticamente aceptable del mismo útil para aumentar y/o proporcionar un inicio más rápido del efecto terapéutico de un inhibidor de la recaptación de serotonina o cualquier otro compuesto que un aumento significativo de la síntesis de receptores 5HT1A postsinápticos en áreas terminales.
Patent AU-2001243396-B2 (AU)
Title: Graft anchor
Inventor: GRAF BEN K
IPC: A61B17/56
Filed: 2001-03-02
Granted: 2004-09-02
Abstract: A device for securing a graft in a bone tunnel includes an anchoring member having a graft supporting surface. The anchoring member is configured to be positioned within the bone tunnel distal of an interference member with the graft retained by the graft supporting surface and extending proximally from the anchoring member. The anchoring member has an engaging surface for engaging a distal end of the interference member to limit movement of the graft relative to the interference member.
Patent AU-2001269683-B2 (AU)
Title: Small technetium-99m and rhenium labeled agents and methods for imaging tumors
Inventor: DAVISON ALAN
IPC: A61P35/00
Filed: 2001-04-27
Granted: 2006-12-21
Abstract: The present invention relates to compounds and related technetium and rhenium complexes thereof which are suitable for imaging or therapeutic treatment of tumors, e.g., carcinomas, melanomas and other tumors. In another embodiment, the invention relates to methods of imaging tumors using radiolabeled metal complexes. Preferred radiolabeled complexes for imaging tumors include technetium and rhenium complexes. The high tumor uptake and significant tumor/nontumor ratios of the technetium complexes of the invention indicate that such small technetium-99m-based molecular probes can be developed as in-vivo diagnostic agents for melanoma and its metastases. In yet another embodiment, the invention relates to methods of treatment of tumors using a radiolabeled metal complex as a radiopharmaceutical agent to treat the tumor.
Patent AU-2002216201-B2 (AU)
Title: A modular system for formation of a prosthesis
Inventor: MESWANIA JAY
IPC: A61F2/38
Filed: 2001-12-07
Granted: 2005-03-10
Abstract: A prosthesis for partial replacement of a long bone in humans or animals, the prosthesis including: a proximal or distal end component forming one component of a prosthetic joint; a shaft on or assembled with the distal or proximal end component in use; a stem for engagement in a resected bone; and an initially separate collar assembled to the shaft or an extension thereof in use, the collar being dimensioned to abut the resected end face of the bone into which the prosthesis is to be fitted, wherein the end face of the collar facing the resected face of the bone is sized and shaped to correspond to the resected end face of the bone.
Patent AU-2002229057-B2 (AU)
Title: Cyclization process step in the making of quinolones and naphthyridines
Inventor: RANDALL JARED LYNN
IPC: C07D401/04
Filed: 2001-12-07
Granted: 2005-04-21
Abstract: Process for making a compound having a structure according to Formula (I), the process comprising reacting an organosilicon reagent with a compound having a structure according to Formula (A).
Patent AU-2002307359-B2 (AU)
Title: Universal multi-variant detection system
Inventor: ANDRUS LINDA
IPC: C12Q1/6818
Filed: 2002-04-17
Granted: 2007-09-13
Abstract: The present invention provides a method to diagnostically detect the variants of a given pathogen, such as HIV, hepatitis C, hepatitis B (HBV), Parvovirus B19, etc., with the use of a single detection probe.